RLMD · Relmada Therapeutics, Inc. · Investor Relations
$2.91
+0.05 (+1.75%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$304.61M
Shares
106.69M
Volume · Nov 19
280.3K
Avg daily vol (3M)
1.41M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-16 | Jefferies Global Healthcare Conference in London | Conference |
| 2026-11-12 | Third Quarter 2026 Earnings Call | Earnings call |
| 2026-08-06 | Q2 2026 Financial Results Conference Call | Earnings call |
| 2026-07-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-27 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-05-18 | American Urology Association (AUA2026) | Event |
| 2026-05-15 | American Urology Association (AUA2026) | Event |
| 2026-05-12 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-19 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-10 | Leerink Partners Global Healthcare Conference | Conference |
| 2025-12-04 | Society of Urologic Oncology 26th Annual Meeting | Shareholder meeting |
| 2025-11-13 | Q3 2025 Financial Results Conference Call | Earnings call |
| 2025-08-07 | Q2 2025 Financial Results Conference Call | Earnings call |
Source: https://ir.relmada.com/
Key facts
CIK
1553643
CUSIP
75955J402
13F (30d)
150 filings
132 filers
Visit website
Investor relations